Sign in

Private company

HESKA CORP

American in vitro and in vivo diagnostic substances company based in Loveland2

In its 2023 annual report the company says: “We sell, manufacture, market and support diagnostic and specialty products and solutions for veterinary practitioners. Our portfolio includes point-of-care diagnostic laboratory instruments and consumables including rapid assay diagnostic products and digital cytology services; POC digital imaging diagnostic products; local and cloud-based data services; practice information management software and related software and support; reference laboratory testing; allergy testing and immunotherapy; heartworm preventive products; and vaccines.”78

Last updated Oct 21, 2026.

Overview

  • IndustryIn Vitro & In Vivo Diagnostic Substances2
  • HeadquartersLoveland, United States2
  • Incorporated inDE3
  • Business address3760 Rocky Mountain Avenue, Loveland, Co 805383
  • Filer categoryLarge accelerated filer3
  • Legal formCorporation2
  • LEI529900O1OR2EB7L0HY272
  • StatusActive2
  • LEI statusLapsed (not renewed)2
  • Registered addressc/o Business Filings Incorporated, 108 West, 13th Street, 19801 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 27339062

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

43.2%Gross margin4
-7.9%Operating margin4
-7.7%Net margin4
1.4%Revenue growth, 20224
-4.7%Return on equity4

Where the money goes

Where each dollar of revenue went, fiscal 2022

  • Cost of revenue57¢$146.1M
  • Research and development8¢$19.8M
  • Other costs33¢$83.8M
  • Interest2¢$4.2M
  • Income tax1¢$3.4M

Out of $257.3M in revenue.4 The company lost money this year.

Financial statements

Revenue5674$257.3M in 2022+98% since 2016
0$100.0M$200.0M$300.0M2016: $130.1M$130.1M20162017: $129.3M$129.3M2017−1%2018: $127.4M$127.4M2018−1%2019: $122.7M$122.7M2019−4%2020: $197.3M$197.3M2020+61%2021: $253.7M$253.7M2021+29%2022: $257.3M$257.3M2022+1%
Gross profit89674$111.2M in 2022+106% since 2016
0$50.0M$100.0M$150.0M2016: $53.9M$53.9M20162017: $58.3M$58.3M2017+8%2018: $56.6M$56.6M2018−3%2019: $54.4M$54.4M2019−4%2020: $81.3M$81.3M2020+49%2021: $105.8M$105.8M2021+30%2022: $111.2M$111.2M2022+5%
Operating income89674-$20.3M in 2022
-$30.0M-$20.0M-$10.0M0$10.0M$20.0M2016: $16.5M$16.5M20162017: $18.2M$18.2M2017+10%2018: $3.8M$3.8M2018−79%2019: $327.0K$327.0K2019−91%2020: -$8.2M-$8.2M20202021: -$993.0K-$993.0K2021−88%2022: -$20.3M-$20.3M2022+1944%
Net income89674-$19.9M in 2022
-$20.0M-$10.0M0$10.0M$20.0M2016: $10.5M$10.5M20162017: $10.0M$10.0M2017−5%2018: $5.8M$5.8M2018−41%2019: -$1.5M-$1.5M20192020: -$14.4M-$14.4M2020+883%2021: -$1.1M-$1.1M2021−92%2022: -$19.9M-$19.9M2022+1632%
Fiscal year2016201720182019202020212022
Revenue$130.1M5$129.3M5$127.4M6$122.7M7$197.3M4$253.7M4$257.3M4
Cost of revenue$76.2M8$71.1M9$70.8M6$68.2M7$116.0M4$147.9M4$146.1M4
Gross profit$53.9M8$58.3M9$56.6M6$54.4M7$81.3M4$105.8M4$111.2M4
Research and development$2.1M8$2.0M9$3.3M6$8.2M7$8.8M4$7.0M4$19.8M4
Operating expenses$106.8M4$131.5M4
Operating income$16.5M8$18.2M9$3.8M6$327.0K7-$8.2M4-$993.0K4-$20.3M4
Interest$160.0K8$245.0K9$310.0K6$3.1M7$6.4M4$4.2M4$4.2M4
Income before tax-$3.4M4-$21.8M4
Income tax$4.3M8$8.9M9-$2.1M6-$1.4M7$239.0K4-$3.6M4-$3.4M4
Net income$10.5M8$10.0M9$5.8M6-$1.5M7-$14.4M4-$1.1M4-$19.9M4
Earnings per share$1.558$1.429$0.816-$0.207-$1.664-$0.114-$1.924
Earnings per share (diluted)$1.438$1.309$0.746-$0.207-$1.664-$0.114-$1.924
Shares (weighted, basic)10.0M shares410.3M shares4
Shares (weighted, diluted)10.0M shares410.3M shares4

Compare HESKA CORP with another company

Corporate structure

HESKA CORP sits at the top of its group. 2 entities, 2 countries on record. Switch between the flow chart and the network, and select any entity to see its details.

Major holders of HESKA CORP

  • Nine Ten Capital Management LLC Filed SC 13G/A on HESKA CORP, latest Apr 10, 2023 (3 filings since Feb 9, 2022)
  • ALGER ASSOCIATES INC Filed SC 13G/A on HESKA CORP, latest Feb 14, 2023 (2 filings since Feb 14, 2022)
  • VANGUARD GROUP INC Filed SC 13G/A on HESKA CORP, latest Feb 9, 2023 (2 filings since Feb 10, 2022)
  • BlackRock Filed SC 13G/A on HESKA CORP, latest Jan 26, 2023 (4 filings since Jan 26, 2022)
  • HESKA CORP Loveland, Colorado, United States
    • scil animal care company GmbH Subsidiary · Viernheim, Germany

Built from parent and subsidiary links from GLEIF, the Global Legal Entity Identifier Foundation (CC0); major holders from Schedules 13D and 13G. Each entity in the chart links to its source.

What it owns

What HESKA CORP reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$71.9M4 Dec 31, 2022$72.2M4 Dec 31, 2021−0.4%
Accumulated depreciation$39.7M4 Dec 31, 2022$38.8M4 Dec 31, 2021+2.4%
Property and equipment, net$32.2M4 Dec 31, 2022$33.4M4 Dec 31, 2021−3.7%
Finance-lease assets$1.5M4 Dec 31, 2022$1.6M4 Dec 31, 2021−10.8%
Operating-lease assets (leased space)$6.9M4 Dec 31, 2022$5.2M4 Dec 31, 2021+32.7%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$156.6M4 Dec 31, 2022$223.6M4 Dec 31, 2021−29.9%
Stakes in other companies (equity method)$941.0K4 Dec 31, 2022$2.4M4 Dec 31, 2021−60.9%

Intangibles and goodwill

ItemLatestA year beforeChange
Goodwill$135.9M4 Dec 31, 2022$118.8M4 Dec 31, 2021+14.4%
Intangible assets, net (excluding goodwill)$62.4M4 Dec 31, 2022$56.7M4 Dec 31, 2021+10.0%
Indefinite-lived intangibles (excluding goodwill)$7.3M4 Dec 31, 2022$7.7M7 Dec 31, 2021−5.6%
Accumulated amortization$22.8M4 Dec 31, 2022$14.5M4 Dec 31, 2021+56.8%
Finite-lived intangibles, net$55.1M4 Dec 31, 2022$49.0M7 Dec 31, 2021+12.5%

Inventory

ItemLatestA year beforeChange
Inventory, total$60.0M4 Dec 31, 2022$49.4M4 Dec 31, 2021+21.7%
Raw materials$21.0M4 Dec 31, 2022$16.1M4 Dec 31, 2021+30.3%
Work in process$4.1M4 Dec 31, 2022$3.7M4 Dec 31, 2021+12.2%
Finished goods$35.0M4 Dec 31, 2022$29.6M4 Dec 31, 2021+18.1%

Leadership

Who has led HESKA CORP, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Robert B. Grieve2006–2014
  2. Kevin S. Wilson2014–2023

Chair

  1. Robert B. Grieve2014–2015

President

  1. Michael J. McGinley2010–2013
  2. Kevin S. Wilson2013–2023

Chief financial officer

  1. Jason A. Napolitano2006–2016
  2. Catherine Grassman2019–2023

Chief operating officer

  1. Michael J. McGinley2010–2013
  2. Kevin S. Wilson2013–2014
  3. Jason A. Napolitano2015–2019
  4. Nancy Wisnewski2020–2022
  5. Eleanor F. Baker2020–2023
2010201520202025
Board members and other officers (35)

Timeline

  1. Jun 13, 20238-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights58
  2. Jun 13, 20238-K Entered a material agreement; Debt or obligation accelerated59
  3. Jun 7, 20238-K Shareholder vote60
  4. Jun 1, 20238-K Other events61
  5. May 26, 20238-K Other events62
  6. May 5, 20238-K Results of operations63
  7. May 3, 20238-K Executive or director change; Shareholder vote64
  8. Apr 3, 20238-K Entered a material agreement; Other events65
  9. Feb 28, 20238-K Results of operations66
  10. Feb 1, 20238-K Executive or director change67
  11. Nov 8, 20228-K Results of operations68
  12. Sep 13, 20228-K Entered a material agreement69
  13. Dec 2, 2014New chief executive Kevin S. Wilson becomes CEO15
  14. Aug 16, 2006New chief executive Robert B. Grieve becomes CEO16

Calendar

When it reported results

  1. May 5, 2023Reported quarterly or annual results63
  2. Feb 28, 2023Reported quarterly or annual results66
  3. Nov 8, 2022Reported quarterly or annual results68
  4. Aug 8, 2022Reported quarterly or annual results70
  5. May 9, 2022Reported quarterly or annual results71
  6. Feb 28, 2022Reported quarterly or annual results72
  7. Nov 4, 2021Reported quarterly or annual results73

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar

Filings

136 filings to the SEC since October 2021: 2 annual reports, 5 quarterly reports, 19 major events, 50 insider forms, 11 large holders, 49 other. The latest 20:

  1. Jun 23, 202315-12G EDGAR
  2. Jun 14, 20234 EDGAR
  3. Jun 14, 20234 EDGAR
  4. Jun 14, 20234 EDGAR
  5. Jun 14, 20234 EDGAR
  6. Jun 14, 20234 EDGAR
  7. Jun 14, 20234 EDGAR
  8. Jun 14, 20234 EDGAR
  9. Jun 14, 20234 EDGAR
  10. Jun 14, 20234 EDGAR
  11. Jun 14, 20234 EDGAR
  12. Jun 14, 20234 EDGAR
  13. Jun 14, 20234 EDGAR
  14. Jun 14, 20234 EDGAR
  15. Jun 13, 2023EFFECT EDGAR
  16. Jun 13, 2023EFFECT EDGAR
  17. Jun 13, 202325-NSE EDGAR
  18. Jun 13, 2023S-8 POS EDGAR
  19. Jun 13, 2023S-8 POS EDGAR
  20. Jun 13, 2023S-8 POS EDGAR

The 136 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

5 open-market trades by officers, directors and large owners since October 2021: 4 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jan 6, 2023Wilson Kevin S.CEO and PresidentBuy11,018$58.62$645.9KForm 4
Dec 22, 2022Wilson Kevin S.CEO and PresidentBuy3,440$59.64$205.2KForm 4
Mar 3, 2022Baker Eleanor F.EVP, Managing Dir. & COO, scilSale663$146.34$97.0KForm 4
Nov 23, 2021Wilson Kevin S.CEO and PresidentBuy1,000$173.00$173.0KForm 4
Nov 15, 2021Wilson Kevin S.CEO and PresidentBuy1,000$179.00$179.0KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

SEC filer profile

How HESKA CORP is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHESKA CORP1
  • CIK0001038133
  • Employer ID (EIN)77-01925271
  • Filer statusLarge accelerated filer1
  • Incorporated inDelaware1
  • Fiscal year endsDecember 311
  • Industry code (SIC)2835 In Vitro & In Vivo Diagnostic Substances1
  • Business address3760 Rocky Mountain Avenue, Loveland, CO 805381
  • Phone97049372721
  • Shares outstanding10,913,754 as of Apr 26, 202312
  • Public float$930.8M as of Jun 30, 20224
  • On EDGAR sinceApr 24, 19971
  • Filings1,489 in all: 4 (773), 8-K (192), 10-Q (78), SC 13G/A (73), 3 (35), DEF 14A (29), 4/A (27), S-8 (26)1
    All 49 form types

    S-8 POS (26), 10-K (25), SC 13G (24), CT ORDER (22), UPLOAD (15), DEFA14A (14), CORRESP (13), PRE 14A (12), 3/A (10), ARS (10), 8-K/A (9), SC 13D/A (7), 10-K/A (6), POS AM (6), 5 (4), S-1/A (4), S-3/A (4), 424B4 (3), D (3), EFFECT (3), S-1 (3), S-3 (3), SC 13D (3), SC 13E3/A (3), SC TO-I/A (3), 10-Q/A (2), 8-A12G/A (2), PRER14A (2), S-3ASR (2), SC TO-I (2), 10-K405 (1), 15-12G (1), 25-NSE (1), 424B1 (1), 424B2 (1), 424B3 (1), 424B5 (1), 8-A12G (1), DEFM14A (1), PREM14A (1), SC 13E3 (1)

  • Latest filingsAnnual report (10-K) Feb 28, 2023
    Quarterly report (10-Q) May 5, 2023
    Proxy statement (DEF 14A) Mar 21, 2023
    Latest 8-K (8-K) Jun 13, 2023

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
    SEC EDGAROther events
  62. 62
    SEC EDGAROther events
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71
  72. 72
  73. 73
  74. 74
  75. 75
  76. 76
  77. 77
  78. 78